Life Sciences Tools and Services
Company Overview of Novartis Institutes for BioMedical Research, Inc.
Novartis Institutes for BioMedical Research, Inc. engages in the research and development of medicines. It focuses on various disease areas, such as immuno-oncology, oncology, neuroscience, cardiovascular and metabolic, autoimmunity, transplantation and inflammatory, infectious, musculoskeletal, ophthalmology, and respiratory. The company was incorporated in 2002 and is based in Cambridge, Massachusetts with research locations in Basel, Switzerland; East Hanover, New Jersey; La Jolla and Emeryville, California; Shanghai, China; and Singapore. Novartis Institutes for BioMedical Research, Inc. operates as a subsidiary of Novartis AG.
250 Massachusetts Avenue
Cambridge, MA 02139
Founded in 2002
Key Executives for Novartis Institutes for BioMedical Research, Inc.
Novartis Institutes for BioMedical Research, Inc. Key Developments
Similar Private Companies By Industry
|10X Genomics, Inc.||United States|
|4G Clinical, Inc.||United States|
|AAPharmaSyn LLC||United States|
|Abiant, Inc.||United States|
|aBioBot, Inc.||United States|
Recent Private Companies Transactions
March 20, 2017
|Cerulean Pharma Inc., Dynamic Tumor Targeting Platform|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Novartis Institutes for BioMedical Research, Inc., please visit www.nibr.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.